5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease

Medical Hypotheses

Volumn 66, Issue 3, 2006, Pages 501-503

  Manev, Hari ^a   Manev, Radmila ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CYCLOOXYGENASE 2 INHIBITOR; ROFECOXIB;

ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; STROKE; TRANSGENIC MOUSE; TREATMENT FAILURE;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ARACHIDONATE 5-LIPOXYGENASE; CARRIER PROTEINS; CROSSES, GENETIC; HUMANS; MEMBRANE PROTEINS; MICE; POLYMORPHISM, GENETIC; RISK FACTORS; VASCULAR DISEASES;

ANIMALIA; MUS MUSCULUS;

EID: 30344484832     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.09.031     Document Type: Article

References (15)

1. S.A. Reines, G.A. Block, J.C. Morris, G. Liu, M.L. Nessly, C.R. Lines Rofecoxib Protocol 091 Study Group Rofecoxib: no effect on Alzheimer's disease in a 1-year randomized, blinded, controlled study Neurology 13 2004 66 71
2. H. Manev 5-Lipoxygenase gene polymorphism and onset of Alzheimer's disease Med Hypotheses 54 2000 75 76
3. T. Qu, R. Manev, and H. Manev 5-Lipoxygenase (5-LOX) promoter polymorphism in patients with early-onset and late-onset Alzheimer's disease J Neuropsychiatry Clin Neurosci 13 2001 304 305
4. M.D. Ikonomovic, E.E. Abrahamson, H. Manev, T. Uz, B. Isanski, and W. Paljug 5-Lipoxygenase protein is elevated in the hippocampus of Alzheimer's disease patients Neurobiol Aging 25 Suppl. 2 2004 S435
5. C. Lendon, and N. Craddock Susceptibility gene(s) for Alzheimer's disease on chromosome 10 Trends Neurosci 24 2001 557 559
6. M. Mehrabian, H. Allayee, J. Wong, W. Shi, X.P. Wang, and Z. Shaposhnik Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice Circ Res 91 2002 120 126
7. J.H. Dwyer, H. Allayee, K.M. Dwyer, J. Fan, H. Wu, and R. Mar Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis New Engl J Med 350 2004 29 37
8. Plante H, Picard S, Mancini J, Borgeat P. 5-Lipoxygenase activating protein homodimer in human neutrophils. Evidence for a role in leukotriene synthesis. Biochem J Sep 7 [Epub ahead of print].
9. A. Helgadottir, A. Manolescu, G. Thorleifsson, S. Gretarsdottir, H. Jonsdottir, and U. Thorsteinsdottir The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke Nat Genet 36 2004 233 239
10. A. Helgadottir, S. Gretarsdottir, D. St Clair, A. Manolescu, J. Cheung, and G. Thorleifsson Association between the gene encoding 5-lipoxygenase- activating protein and stroke replicated in a Scottish population Am J Hum Genet 76 2005 505 509
11. J.F. Meschia, T.G. Brott, R.D. Brown Jr., R. Crook, B.B. Worrall, and B. Kissela Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke Ann Neurol 58 2005 351 361
12. J.C. de la Torre Alzheimer's disease is a vasocognopathy: a new term to describe its nature Neurol Res 26 2004 517 524
13. J.A. Luchsinger, C. Reitz, L.S. Honig, M.X. Tang, S. Shea, and R. Mayeux Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology 65 2005 545 551
14. A.G. Yip, A.C. McKee, R.C. Green, J. Wells, H. Young, and L.A. Cupples APOE, vascular pathology, and the AD brain Neurology 65 2005 259 265
15. H. Manev, and R.M. Manev Possible genetic predisposition to cardiac effects Med J Aust 182 2005 198